An analyst from Credit Suisse maintained Homology Medicines (NASDAQ: FIXX) at 'neutral' with a price target of $1.70 from a prior price target of %currency%%price%. Prior to this rating,...
Investing.com - Homology Medicines (NASDAQ: FIXX) reported second quarter EPS of $-0.610, $0.11 worse than the analyst estimate of $-0.500. Revenue for the quarter came in at $354K versus...
New York, USA, July 31, 2023 (GLOBE NEWSWIRE) -- Phenylketonuria Market to Exhibit Significant Growth, Assesses DelveInsight | Key Companies - BioMarin, Synlogic, PTC Therapeutics, Jnana...
Homology Medicines Inc (NASDAQ: FIXX) announced initial data from the first dose cohort in the pheEDIT Phase 1 dose-escalation trial evaluating gene editing candidate HMI-103 in adults...
An analyst from Baird downgraded Homology Medicines (NASDAQ: FIXX) from 'outperform' to 'neutral' with a price target of $1.50 from a prior price target of %currency%%price%. Prior to this...
Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today encouraging initial clinical data from the first dose cohort in the pheEDIT Phase 1, dose-escalation...
Homology Medicines Inc. (FIXX) Halted, News Pending
Investing.com - Homology Medicines (NASDAQ: FIXX) reported first quarter EPS of $-0.500, $0.02 better than the analyst estimate of $-0.520. Revenue for the quarter came in at $800K versus...
Investing.com - Homology Medicines (NASDAQ: FIXX) reported first quarter EPS of $-0.600, $0.11 worse than the analyst estimate of $-0.492. Revenue for the quarter came in at $802K versus the...
Homology Medicines, Inc. (Nasdaq: NASDAQ:FIXX), a genetic medicines company, announced today that Julie Jordan, M.D., has been promoted to Chief Medical Officer. Previously, Dr. Jordan held...
Homology Medicines, Inc. (Nasdaq: NASDAQ:FIXX), a genetic medicines company, announced today the presentation of preclinical data that supports the targeted, prophylactic immunosuppression...
Investing.com - Homology Medicines reported on Thursday third quarter {{erl-1073036||earnings that missed analysts' forecasts and revenue that fell short of expectations. Homology...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Technology, Oil & Gas and Financials sectors propelled shares higher while losses in the Basic Materials,...
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Basic Materials, Oil & Gas and Financials sectors propelled shares lower. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
